Eton Pharmaceuticals Inc (ETON)
3.715
-0.04
(-0.93%)
USD |
NASDAQ |
May 07, 16:00
3.715
0.00 (0.00%)
After-Hours: 17:16
Eton Pharmaceuticals Cash from Financing (TTM): -0.957M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.957M |
September 30, 2023 | -0.564M |
June 30, 2023 | -0.161M |
March 31, 2023 | 0.202M |
December 31, 2022 | -0.134M |
September 30, 2022 | -0.165M |
June 30, 2022 | -0.341M |
March 31, 2022 | -0.097M |
December 31, 2021 | 0.391M |
September 30, 2021 | 21.51M |
June 30, 2021 | 23.81M |
Date | Value |
---|---|
March 31, 2021 | 24.24M |
December 31, 2020 | 31.62M |
September 30, 2020 | 15.36M |
June 30, 2020 | 13.28M |
March 31, 2020 | 12.69M |
December 31, 2019 | 5.203M |
September 30, 2019 | 22.24M |
June 30, 2019 | 22.16M |
March 31, 2019 | 21.96M |
December 31, 2018 | 21.96M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.957M
Minimum
Dec 2023
31.62M
Maximum
Dec 2020
10.02M
Average
5.203M
Median
Dec 2019
Cash from Financing (TTM) Benchmarks
Eli Lilly and Co | 2.772B |
Evoke Pharma Inc | -0.1193M |
Outlook Therapeutics Inc | 5.120M |
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |